2001•Journal of Clinical CardiologyRequires access

A clinical study on combination of captopril and spironolactone in aged patients with congestive heart failure and ventricular arrhythmia

Yang Jingning

Open publisher page 0 citations

Abstract

Objective: To study on the cli n ical effect and safety of combination of captopril and spironolactone in aged pa tients with congestive heart failure (CHF) and ventricular arrhythmia. Method: Two hundred aged patients with CHF and ventricular arrhythmia were enrolled in this clinical study. Observation of the alternation of heart function and the clinical effects was made after using captopril and s pironolactone. Result: Ventricular premature beat of 98% cases reduced ob viously. Partial ventricular tachycardia or R on T phenomena of some patients disappeard. Furthermore, the heart function of 96% patients improved to over 1 class (by NYHA) and clinical signs changed better obviously. Potassium ions of all cases kept stable within normal limits and nobody got hyperpotassemia. Conclusion: The combination of captopril and spironolacton e is absolutely reliable and safe for the aged patients with CHF and worth popul arizing.

About this research paper

What this paper is about

Objective: To study on the cli n ical effect and safety of combination of captopril and spironolactone in aged pa tients with congestive heart failure (CHF) and ventricular arrhythmia. Method: Two hundred aged patients with CHF and ventricular arrhythmia were enrolled in this clinical study. Observation of the alternation of heart function and the clinical effects was made after using captopril and s pironolactone. Result: Ventricular premature beat of 98% cases reduced ob viously. Partial ventricular tachycardia or R on T phenomena of some patients disappeard. Furthermore, the heart function of 96% patients improved to over 1 class (by NYHA) and clinical signs changed better obviously. Potassium ions of all cases kept stable within normal limits and nobody got hyperpotassemia. Conclusion: The combination of captopril and spironolacton e is absolutely reliable and safe for the aged patients with CHF and worth popul arizing.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study on the cli n ical effect and safety of combination of captopril and spironolactone in aged pa tients with congestive heart failure (CHF) and ventricular arrhythmia. Method: Two hundred aged patients with CHF and ventricular arrhythmia were enrolled in this clinical study. Observation of the alternation of heart function and the clinical effects was made after using captopril and s pironolactone. Result: Ventricular premature beat of 98% cases reduced ob viously. Partial ventricular tachycardia or R on T phenomena of some patients disappeard. Furthermore, the heart function of 96% patients improved to over 1 class (by NYHA) and clinical signs changed better obviously. Potassium ions of all cases kept stable within normal limits and nobody got hyperpotassemia. Conclusion: The combination of captopril and spironolacton e is absolutely reliable and safe for the aged patients with CHF and worth popul arizing.

Key concepts: Captopril, Medicine, Spironolactone, Internal medicine, Cardiology, Heart failure, Ventricular tachycardia, Hyperkalemia

Related papers

Back to paper searchBrowse research topicsOriginal source
A clinical study on combination of captopril and spironolactone in aged patients with congestive heart failure and ventricular arrhythmia — Research Paper | ScholarLens